期刊文献+

组蛋白去乙酰化酶5在胃癌中的表达及与肿瘤免疫微环境的关系

Expression of histone deacetylase 5 in gastric cancer and its relationship with tumor immune microenvironment
下载PDF
导出
摘要 目的探讨组蛋白去乙酰化酶5(HDAC5)在胃癌中的表达及与肿瘤免疫微环境的关系。方法回顾性分析本院2021年2月—2023年12月诊治的120例胃癌患者的临床资料。采用免疫组化分析法检测患者胃癌组织中HDAC5的表达水平,并将患者分为HDAC5高表达组与低表达组。采用单因素分析、多因素Logistic回归分析及受试者工作特征(ROC)曲线探讨影响HDAC5表达的相关因素;检测2组组织中外周血调节性T细胞(Treg)、肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、降钙素原(PCT)、超敏C反应蛋白(hs-CRP)、免疫球蛋白A(IgA)、免疫球蛋白M(IgM)、免疫球蛋白G(IgG)水平;采用Pearson相关分析验证HDAC5在胃癌中的表达水平与肿瘤免疫微环境的相关性。结果单因素分析结果显示,2组肿瘤直径、Borrmann分型、淋巴结转移情况的差异有统计学意义(P<0.05)。多因素Logistic回归分析结果显示,肿瘤直径、Borrmann分型以及淋巴结转移情况是HDAC5在胃癌中表达水平的独立影响因素(P<0.05)。ROC曲线分析结果显示,肿瘤直径、Borrmann分型以及淋巴结转移情况的曲线下面积(AUC)分别为0.608、0.593、0.614。Pearson相关分析结果显示,胃癌患者的HDAC5表达水平与Treg含量、炎症介质指标均呈正相关(P<0.05),与IgA、IgM、IgG呈负相关(P<0.05)。结论在胃癌患者中,HDAC5的表达水平与肿瘤直径、Borrmann分型以及淋巴结转移情况相关,高水平的HDAC5会直接影响胃癌的肿瘤免疫微环境。 Objective To investigate the expression of histone deacetylase 5(HDAC5)in gastric cancer and its relationship with tumor immune microenvironment.Methods Clinical materials of 120 patients with gastric cancer diagnosed and treated in the hospital from February 2021 to December 2023 were retrospectively analyzed.Immunohistochemical analysis was used to detect the expression level of HDAC5 in gastric cancer tissues,and the patients were divided into HDAC5 high-expression group and low-expression group.Univariate analysis,Logistic regression analysis,and receiver operating characteristic(ROC)curve were used to explore the related factors affecting HDAC5 expression.The levels of regulatory T cells(Treg),tumor necrosis factor-α(TNF-α),interleukin-1β(IL-1β),interleukin-6(IL-6),procalcitonin(PCT),hypersensitive C-reactive protein(hs-CRP),immunoglobulin A(IgA),immunoglobulin M(IgM),and immunoglobulin G(IgG)in both groups were detected.Pearson correlation analysis was used to verify the correlation between HDAC5 expression level and tumor immune microenvironment in gastric cancer.Results Univariate analysis showed that there were significant differences in tumor diameter,Borrmann classification and lymph node metastasis between the two groups(P<0.05).Logistic regression analysis showed that tumor diameter,Borrmann classification and lymph node metastasis were independent risk factors affecting HDAC5 expression in gastric cancer(P<0.05).ROC curve analysis showed that the values of area under the curve(AUC)for tumor diameter,Borrmann classification and lymph node metastasis were 0.608,0.593 and 0.614,respectively.Pearson correlation analysis showed that HDAC5 expression level in gastric cancer patients was positively correlated with Treg content and inflammatory mediator indexes(P<0.05),and negatively correlated with IgA,IgM and IgG(P<0.05).Conclusion In patients with gastric cancer,the expression level of HDAC5 is related to tumor diameter,Borrmann classification and lymph node metastasis.High-level HDAC5 can directly affect the tumor immune microenvironment of gastric cancer.
作者 顾建建 GU Jianjian(Tongzhou District People′s Hospital of Nantong City in Jiangsu Province,Nantong,Jiangsu,226300)
出处 《实用临床医药杂志》 CAS 2024年第12期51-56,共6页 Journal of Clinical Medicine in Practice
关键词 胃癌 组蛋白去乙酰化酶5 肿瘤免疫微环境 相关性 肿瘤直径 淋巴结转移 gastric cancer histone deacetylase 5 tumor immune microenvironment correlation tumor diameter lymph node metastasis
  • 相关文献

参考文献19

二级参考文献77

  • 1党艳妮,黄壮壮,苏英英,杜霞,魏小亮,刘峰.基于网络药理学的黄精抗肿瘤成分筛选研究[J].药物评价研究,2020,0(3):468-472. 被引量:12
  • 2诸芳芳.血清CEA、CA19-9检测对老年胃癌诊断的临床价值[J].中国老年学杂志,2014,34(10):2864-2865. 被引量:5
  • 3李晟磊,赵秋民,刘宗文,赵志华,高冬玲,郑湘予,陈奎生,张云汉.食管鳞癌中RECK和MMP-9蛋白表达的相关性及临床病理意义[J].世界华人消化杂志,2007,15(10):1082-1086. 被引量:34
  • 4张波,刘科,陈道达.曲古菌素A对结肠癌Lovo细胞增殖抑制的研究[J].中国普通外科杂志,2007,16(6):574-576. 被引量:4
  • 5VERDIN E,DEQUIEDT F,KASLER H G.ClassⅡhistone deacetylases:versatile regulators[J].Trends Genet,2003,19(5):286-293.
  • 6SAKUMA T,UZAWA K,ONDA T,et al.Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma[J].Int J Oncol,2006,29(1):117-124.
  • 7ARTS J,ANGIBAUD P,MARIЁN A,et al.R306465 is a novel potent inhibitor of class Ⅰ histone deacetylases with broad-spectrum antitumoral activity against solid and haematological malignancies[J].Br J Cancer,2007,97(10):1344-1353.
  • 8MARKS P A,MILLER T,RICHON V M.Histone deacetylases[J].Curr Opin Pharmacol,2003,3(4):344-351.
  • 9MARCUS A I,ZHOU J,O′BRATE A,et al.The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclita xel enhances tubulin acetylation and requires a functional tubulin deacetylase[J].Cancer Res,2005,65(9):3883-3893.
  • 10SAJI S,KAWAKAMI M,HAYASHI S,et al.Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer[J].Oncogene,2005,24(28):4531-4539.

共引文献167

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部